Evidence map›Paper›PMID 37457812›Full record

ArticleIDCases2023

Focal pachymeningitis in a returning traveler: Don't forget melioidosis.

Alexis Demas, Franck Labbé, Anne Vandendriessche, Vincent Langlois

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Travel-Associated Melioidosis in Non-Endemic Regions: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2025
    Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexis DemasNeurology Unit, Hospital of Le Havre, Department of Neurology, Le Havre Hospital, 29 avenue Pierre Mendes, 76290, Le Havre Cedex, France.
Franck LabbéBiology Services, Hospital of Le Havre, Department of Biology Le Havre Hospital, 29 avenue Pierre Mendes, 76290, Le Havre Cedex, France.
Anne VandendriesscheInfectious Diseases Unit, Hospital of Le Havre, Department of Infectious Diseases, Le Havre Hospital, 29 avenue Pierre Mendes, 76290, Le Havre Cedex, France.
Vincent LangloisDepartment of Infectious Diseases and Internal Medicine, Le Havre Hospital, 29 avenue Pierre Mendes, 76290, Le Havre Cedex, France.
Université Le Havre Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Melioidosis is an endemic disease in South-East Asia and Northern Australia caused by a Gram-negative bacillus, Methods: In this paper, we report a patient returning from Asia with an unusual infection including CNS involvement consistent with a melioidosis. Results: This diagnosis was challenging and complex to carry out with multiple considerations, mainly because of the atypical nature of the germ. Conclusions: This case of melioidosis shows the difficulty regarding the diagnosis of this disease in a patient returning from an endemic zone and its frequent multiple organs involvement. Melioidosis is an emerging, potentially fatal disease which requires prolonged antibiotic treatment. Difficulties in clinical microbiology laboratories diagnosis of melioidosis, especially in non-endemic areas where clinical suspicion is low, may delay treatment and affect disease outcomes.

Indexed as

EpidemiologyInfectious DiseaseMelioidosisMRIPachymeningitis

Identifiers

PMID37457812
PMCPMC10339118
OpenAlexW4383197937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.